Khan Shagufta, Kataria Prashant, Nakhat Premchand, Yeole Pramod
Institute of Pharmaceutical Education and Research, Borgaon (Meghe), Wardha, Maharashtra, India.
AAPS PharmSciTech. 2007 Jun 22;8(2):Article 46. doi: 10.1208/pt0802046.
The purpose of this research was to mask the intensely bitter taste of ondansetron HCl and to formulate a rapid-disintegrating tablet (RDT) of the taste-masked drug. Taste masking was done by complexing ondansetron HCl with aminoalkyl methacrylate copolymer (Eudragit EPO) in different ratios by the precipitation method. Drug-polymer complexes (DPCs) were tested for drug content, in vitro taste in simulated salivary fluid (SSF) of pH 6.2, and molecular property. Complex that did not release drug in SSF was considered taste-masked and selected for formulation RDTs. The complex with drug-polymer ratio of 8:2 did not show drug release in SSF; therefore, it was selected. The properties of tablets such as tensile strength, wetting time, water absorption ratio, in vitro disintegration time, and disintegration in the oral cavity were investigated to elucidate the wetting and disintegration characteristics of tablets. Polyplasdone XL-10 7% wt/wt gave the minimum disintegration time. Tablets of batch F4 containing spray-dried mannitol and microcrystalline cellulose in the ratio 1:1 and 7% wt/wt Polyplasdone XL-10 showed faster disintegration, within 12.5 seconds, than the marketed tablet (112 seconds). Good correlation between in vitro disintegration behavior and in the oral cavity was recognized. Taste evaluation of RDT in human volunteers revealed considerable taste masking with the degree of bitterness below threshold value (0.5) ultimately reaching to 0 within 15 minutes, whereas ondansetron HCl was rated intensely bitter with a score of 3 for 10 minutes. Tablets of batch F4 also revealed rapid drug release (t(90), 60 seconds) in SGF compared with marketed formulation (t(90), 240 seconds; P < .01). Thus, results conclusively demonstrated successful masking of taste and rapid disintegration of the formulated tablets in the oral cavity.
本研究的目的是掩盖盐酸昂丹司琼的强烈苦味,并制备该掩味药物的速崩片(RDT)。通过沉淀法将盐酸昂丹司琼与不同比例的甲基丙烯酸氨基烷基酯共聚物(Eudragit EPO)络合来实现掩味。对药物 - 聚合物络合物(DPCs)进行药物含量、pH 6.2模拟唾液(SSF)中的体外味觉以及分子性质测试。在SSF中不释放药物的络合物被视为掩味,并被选用于制备RDT。药物 - 聚合物比例为8:2的络合物在SSF中未显示药物释放;因此,它被选中。研究了片剂的拉伸强度、润湿时间、吸水率、体外崩解时间和口腔内崩解等性质,以阐明片剂的润湿和崩解特性。7%重量/重量的交联聚维酮XL - 10给出了最短的崩解时间。含有喷雾干燥甘露醇和微晶纤维素比例为1:1以及7%重量/重量交联聚维酮XL - 10的F4批次片剂显示出比市售片剂(112秒)更快的崩解,在12.5秒内。体外崩解行为与口腔内崩解行为之间具有良好的相关性。在人类志愿者中对RDT进行的味觉评估显示出显著的掩味效果,苦味程度低于阈值(0.5),最终在15分钟内降至0,而盐酸昂丹司琼被评为强烈苦味,10分钟内评分为3。与市售制剂相比,F4批次片剂在模拟胃液(SGF)中也显示出快速的药物释放(t(90),60秒)(市售制剂t(90),240秒;P <.01)。因此,结果最终证明了所制备片剂成功实现了掩味和在口腔内的快速崩解。